The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies ...
In daily pediatric practice, shared decision-making is already happening, often more than is acknowledged,” a pediatrician writes.
European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...
The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the ...
According to “Why Should I Trust You?” hosts Tom W. Johnson and Brinda Adhikari, public health’s disengagement from MAHA has ...
The South Carolina measles outbreak has surpassed the recorded case count in Texas' 2025 outbreak, as health officials have ...
A majority of respondents (67%) say Congress did the “wrong thing” by not yet extending the ACA enhanced premium tax credits, though judgement fell largely across party lines. While 89% of Democrats ...
Glioblastoma is almost always fatal. Altido Bio is trying to commercialize a CAR-T cell therapy that has shown rare promise.
A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...
Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work ...
Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...
AstraZeneca will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results